This application from the Center for Cell and Gene Therapy (CAGT) / Baylor College of Medicine (BCM) describes a comprehensive training program in cellular and genetic therapies, for both graduate students and postdoctoral fellows. This burgeoning area of translational research remains deficient in comprehensive training schemes for individuals who wish to address basic and clinical translational aspects using these biological agents. A stimulating program of education and laboratory training from high quality mentors should continue to attract promising candidates, including under-represented minorities, to this emerging field and increase the likelihood that they will pursue careers as translational researchers. Translation of basic research discoveries to clinical practice has become increasingly complex, such that advances in basic research can only be efficiently implemented when teams of investigators collaborate to validate these novel strategies in the clinic. This type of translational research training requires the involvement of a dedicated team of mentors with diverse but complementary skills. The proposed training exploits the outstanding biomedical curricula and experienced faculty within BCM and CAGT. A cadre of 26 faculty members with research interests that include vector design and targeting, stem cell biology, molecular and cellular genetics, immunotherapy, gene therapy and stem cell transplantation will be available to mentor graduate students and both MD and PhD postdoctoral fellows. Major strengths of the program are its;(1) targeting of rigorous basic biomedical science and clinical research training toward a translational goal;(2) established and multilevel integration with the proven scientific excellence of cell biology and genetics research training programs at BCM;(3) involvement of mentors, including program director and co directors, who have a wealth of experience in translational research and in training young investigators (4) availability of unique resources such as the GMP laboratories for training. Augmenting the formal course work and laboratory training will be opportunities to present recent research findings at annual retreats sponsored by CAGT and academic departments within BCM. During the first 8 years of funding this approach has successfully trained 14 graduate students who have completed their PhD degrees: all remain in academic medicine. Eight postdoctoral fellows have completed training in translational cell and gene therapy research and all remain in the field with 5 appointed to academic faculty positions and 3 in biotechnology. Of all trainees who have completed training or who are still in training 9 are under- represented minorities and 3 have under-privileged backgrounds. The maintenance of support will allow us to continue to provide trainees with a strong foundation for translational research careers in this emerging area.

Public Health Relevance

This proposal aims to train young researchers so that they can move cell and gene based therapies from basic science laboratories and into the clinic. These therapies hold great promise for regenerative medicine, cancer and other disorders, but can only be implemented after the specialized training that this award will provide

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL092332-11
Application #
8414195
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Welniak, Lisbeth A
Project Start
2003-07-01
Project End
2018-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
11
Fiscal Year
2013
Total Cost
$298,046
Indirect Cost
$20,328
Name
Baylor College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Rosewell Shaw, Amanda; Suzuki, Masataka (2018) Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment. Front Immunol 9:2103
Samaha, Heba; Pignata, Antonella; Fousek, Kristen et al. (2018) A homing system targets therapeutic T cells to brain cancer. Nature 561:331-337
Kruse, Robert L; Shum, Thomas; Tashiro, Haruko et al. (2018) HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice. Cytotherapy 20:697-705
Scavuzzo, Marissa A; Hill, Matthew C; Chmielowiec, Jolanta et al. (2018) Endocrine lineage biases arise in temporally distinct endocrine progenitors during pancreatic morphogenesis. Nat Commun 9:3356
Morales-Mantilla, Daniel E; King, Katherine Y (2018) The Role of Interferon-Gamma in Hematopoietic Stem Cell Development, Homeostasis, and Disease. Curr Stem Cell Rep 4:264-271
Pankowicz, Francis P; Barzi, Mercedes; Kim, Kang Ho et al. (2018) Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing. Gastroenterology 155:1967-1970.e6
Scavuzzo, Marissa A; Teaw, Jessica; Yang, Diane et al. (2018) Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro. J Vis Exp :
Byrd, Tiara T; Fousek, Kristen; Pignata, Antonella et al. (2018) TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res 78:489-500
Arasaratnam, R J; Tzannou, I; Gray, T et al. (2018) Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients. Am J Transplant 18:2238-2249
Shum, Thomas; Kruse, Robert L; Rooney, Cliona M (2018) Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities. Expert Opin Biol Ther 18:653-664

Showing the most recent 10 out of 138 publications